Strategy Asset Managers LLC acquired a new stake in shares of Globe Life Inc. (NYSE:GL – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The fund acquired 4,312 shares of the company’s stock, valued at approximately $714,000.
Other hedge funds also recently made changes to their positions in the company. Contravisory Investment Management Inc. increased its holdings in Globe Life by 4.3% in the 3rd quarter. Contravisory Investment Management Inc. now owns 6,782 shares of the company’s stock worth $1,123,000 after acquiring an additional 282 shares in the last quarter. NorthCrest Asset Manangement LLC raised its stake in Globe Life by 8.6% during the 3rd quarter. NorthCrest Asset Manangement LLC now owns 1,937 shares of the company’s stock worth $322,000 after acquiring an additional 154 shares during the period. GAMMA Investing LLC raised its stake in Globe Life by 2.4% during the 3rd quarter. GAMMA Investing LLC now owns 7,943 shares of the company’s stock worth $1,316,000 after acquiring an additional 189 shares during the period. Westwind Capital lifted its holdings in Globe Life by 5.7% during the third quarter. Westwind Capital now owns 10,187 shares of the company’s stock valued at $1,687,000 after purchasing an additional 545 shares in the last quarter. Finally, QRG Capital Management Inc. lifted its holdings in Globe Life by 16.7% during the second quarter. QRG Capital Management Inc. now owns 7,790 shares of the company’s stock valued at $1,392,000 after purchasing an additional 1,113 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on the stock. Keefe, Bruyette & Woods dropped their price target on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research report on Friday, July 24th. Jefferies Financial Group raised their price objective on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research report on Friday, July 10th. Wells Fargo & Company lifted their target price on shares of Globe Life from $190.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday. JPMorgan Chase & Co. lifted their target price on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Finally, Morgan Stanley dropped their target price on shares of Globe Life from $208.00 to $197.00 and set an “overweight” rating for the company in a report on Monday, October 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, Globe Life has a consensus rating of “Moderate Buy” and an average target price of $190.22.
Insider Activity at Globe Life
In other news, CEO James Darden sold 50,000 shares of Globe Life stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the sale, the chief executive officer owned 58,451 shares in the company, valued at $10,663,215.93. This trade represents a 46.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Robert Hensley sold 10,000 shares of the business’s stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $170.07, for a total transaction of $1,700,700.00. Following the completion of the transaction, the executive vice president directly owned 12,384 shares in the company, valued at $2,106,146.88. This trade represents a 44.67% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 143,650 shares of company stock valued at $25,793,717. Corporate insiders own 2.11% of the company’s stock.
Globe Life Stock Performance
NYSE:GL opened at $167.43 on Thursday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 12-month low of $127.85 and a 12-month high of $191.55. The stock has a 50-day moving average price of $172.11 and a 200 day moving average price of $166.02. The stock has a market capitalization of $12.87 billion, a P/E ratio of 11.12 and a beta of 0.44.
Globe Life (NYSE:GL – Get Free Report) last issued its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the business posted $3.05 EPS. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities research analysts forecast that Globe Life Inc. will post 15.70 EPS for the current fiscal year.
Globe Life Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s dividend payout ratio (DPR) is 8.76%.
Globe Life announced that its Board of Directors has approved a stock repurchase program on Monday, August 10th that authorizes the company to buy back $2.50 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 17.7% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its shares are undervalued.
Globe Life Profile
Globe Life Inc (NYSE: GL) is an insurance holding company that provides life and supplemental health insurance products to individuals and families in the United States. Its offerings include term and whole life insurance, mortgage protection coverage, accident and supplemental health policies, and Medicare supplement insurance.
The company distributes its products through a network of insurance agencies, independent agents, and direct-to-consumer channels. Its principal insurance businesses include Globe Life and Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, and Family Heritage Life Insurance Company.
Recommended Stories
- Five stocks we like better than Globe Life
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
